Essential Facts About ON Semiconductor

Large-cap Technology company ON Semiconductor has logged a 0.6% change today on a trading volume of 884,434. The average volume for the stock is 6,272,595.

ON Semiconductor Corporation provides intelligent sensing and power solutions in the United States and internationally. Based in Scottsdale, United States the company has 31,000 full time employees and a market cap of $28,697,405,440.

The company is now trading -44.24% away from its average analyst target price of $119.5 per share. The 24 analysts following the stock have set target prices ranging from $95.0 to $135.0, and on average give ON Semiconductor a rating of buy.

Over the last 12 months ON shares have declined by -1.0%, which represents a difference of -16.0% when compared to the S&P 500. The stock's 52 week high is $111.35 per share and its 52 week low is $59.61. Based on ON Semiconductor's average net margin growth of 13.4% over the last 6 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 8,350,300 1,956,300 23 0.0
2022 8,326,200 1,904,200 23 53.33
2021 6,739,800 1,011,200 15 275.0
2020 5,255,000 236,400 4 0.0
2019 5,517,900 213,900 4 -63.64
2018 5,878,300 629,900 11
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS